SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-004373
Filing Date
2023-02-24
Accepted
2023-02-24 16:06:47
Documents
13
Period of Report
2023-02-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-20230224.htm   iXBRL 8-K 72361
2 EX-3.1 stro-ex3_1.htm EX-3 354713
  Complete submission text file 0000950170-23-004373.txt   595800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20230224.xsd EX-101.SCH 2464
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20230224_pre.xml EX-101.PRE 11487
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20230224_lab.xml EX-101.LAB 14199
7 EXTRACTED XBRL INSTANCE DOCUMENT stro-20230224_htm.xml XML 4933
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 23667049
SIC: 2836 Biological Products, (No Diagnostic Substances)